1. Obesity and overweight. Available: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight [Accessed 15 Oct 2021].
2. Healthy weight loss maintenance with exercise, liraglutide, or both combined;Lundgren;N Engl J Med,2021
3. Progress and challenges in anti-obesity pharmacotherapy;Bessesen;Lancet Diabetes Endocrinol,2018
4. High dose Semaglutide for weight loss and cardiometabolic risk reduction in Overweight/Obesity. American College of cardiology. Available: https://www.acc.org/latest-in-cardiology/articles/2021/07/21/14/06/http%3a%2f%2fwww.acc.org%2flatest-in-cardiology%2farticles%2f2021%2f07%2f21%2f14%2f06%2fhigh-dose-semaglutide-for-weight-loss-and-cardiometabolic-risk-reduction [Accessed 31 Oct 2021].
5. Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5;Kushner;Obesity,2020